EV/EBITDA
-10.42
-0.18-1.76%
Thu, 06 Mar 2025 00:42:21 GMT
Summary
- As of March 6, 2025, CRVS EV/EBITDA is -10.42, with a fall of -0.18 (-1.76%) during the most recent trading day.
- Over the past year, CRVS EV/EBITDA has dropped by -6.45 (-162.47%).
- CRVS EV/EBITDA is now -113.95% below its all-time high of 74.68.
Performance
CRVS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CRVS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.8% | +1.8% | +1.7% |
| 1 m1 month | +24.8% | -24.9% | -24.5% |
| 3 m3 months | +49.7% | -49.7% | -49.3% |
| 6 m6 months | -5.7% | +13.3% | +5.6% |
| ytdytd | +23.0% | -23.0% | -22.7% |
| 1 y1 year | -162.5% | +182.4% | +95.3% |
| 5 y5 years | -408.3% | +164.3% | +14.6% |
CRVS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -4.7% | -13.86 | +24.8% | |
| 3 m | 3-month | -9.95 | -4.7% | -22.96 | +54.6% |
| 6 m | 6-month | -9.86 | -5.7% | -24.17 | +56.9% |
| 1 y | 1-year | -2.62 | -297.7% | -24.17 | +56.9% |
| 3 y | 3-year | -0.22 | -4636.4% | -24.17 | +56.9% |
| 5 y | 5-year | -0.22 | -4636.4% | -24.17 | +56.9% |
| alltime | all time | 74.68 | -114.0% | -2438 | +99.6% |
Corvus Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -10.42(-23.0%) |
| 2024 | -13.53(+321.5%) |
| 2023 | -3.21(+256.7%) |
| 2022 | -0.90(-35.3%) |
| 2021 | -1.39(-30.8%) |
| Date | Value |
|---|---|
| 2020 | -2.01(-35.6%) |
| 2019 | -3.12(+121.3%) |
| 2018 | -1.41(-54.5%) |
| 2017 | -3.10(-61.6%) |
| 2016 | -8.08 |
FAQ
- What is Corvus Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Corvus Pharmaceuticals?
- What is CRVS EV/EBITDA year-to-date change?
- What is Corvus Pharmaceuticals EV/EBITDA year-on-year change?
What is Corvus Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of CRVS is -10.42
What is the all time high EV/EBITDA for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high EV/EBITDA is 74.68
What is CRVS EV/EBITDA year-to-date change?
Corvus Pharmaceuticals EV/EBITDA has changed by +3.11 (+22.99%) since the beginning of the year
What is Corvus Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, CRVS EV/EBITDA has changed by -6.45 (-162.47%)